Clinical studies reveal that HCC patients show a distinct signature of TGF‐β gene expression and the signature correlates with tumor invasiveness, the time before relapse, and long‐term survival of the patient.103. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.